CLCharles T. Lutz

Charles T. Lutz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charles T. Lutz has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lifespan Socioeconomic Context Is Associated With Cytomegalovirus and Late-Differentiated CD8+ T and Natural Killer Cells: Initial Results in Older Adults

    by Rebecca G. Reed, Abby R. Hillmann, Steven R. Presnell, Ahmad Al-Attar, Charles T. Lutz, Suzanne C. Segerstrom

    Objective: Lower socioeconomic status (SES) can accelerate immune aging; however, it is unknown whether and how lifespan socioeconomic context (SEC)—the relative wealth and quality of the communities an individual lives in across their lifespan—impacts immune aging. We examined the effects of childhood and adulthood SEC on late-differentiated immune cells and investigated the mediating and moderating role of cytomegalovirus (CMV), a key driver of immune aging. Methods: Adults 60 years and older (N = 109) reported their addresses from birth to age 60 years, which were coded for county-level employment, education, and income to construct a latent SEC variable, averaged across ages 0 to 18 years (childhood SEC) and 19 to 60 years (adulthood SEC). Blood was drawn semiannually for 5 years for CMV serostatus and flow cytometry estimates of late-differentiated CD8+ T and natural killer cells. Models were adjusted for chronological age, time, sex, and individual SES (current income and education). Results: Lower childhood SEC was associated with higher percentages of late-differentiated CD8+ T and natural killer cells via CMV seropositivity (indirect effects, p values = .015–.028). In addition, an interaction between CMV serostatus and SEC on CD8+ T-cell aging (p = .049) demonstrated that adulthood SEC was negatively associated with immune aging among CMV− but not CMV+ adults. Conclusions: Beyond current SES, SEC related to immune aging in distinct patterns by lifespan phase. Lower childhood SEC importantly may influence who acquires CMV, which in turn predicts higher levels of immune aging, whereas higher adulthood SEC was protective against immune aging among CMV− older adults. These initial results need to be explored in larger samples.


  • Resources and lymphocyte terminal maturity among older adults.

    by Suzanne C. Segerstrom, Rebecca G. Reed, Steven R. Presnell, Ahmad Al-Attar, Charles T. Lutz

    Objective: Women's financial resources were associated with more terminal maturity in natural killer lymphocytes, generally associated with loss of proliferative potential, during the "Great Recession". This preregistered analysis expanded on that finding in a longitudinal design including both genders and examining the role of cytomegalovirus (CMV) serostatus. Method: Older adults (N = 138, 57% women) were assessed longitudinally during 2012-2017; including self-reported psychological, social, financial, and status-skill resources, CMV antibody titers and serostatus, and assessment of T and natural killer lymphocyte terminal maturity (LTM). Results: Neither total nor financial resources were associated with LTM. Adjusting only for age, more psychological resources (e.g., meaning, hope, humor) were associated with lower T LTM (percent: gamma = -1.11 [-1.78, -.44]; number: gamma = -.99 [-1.70, -.27]). There were no significant interactions with age, gender, or CMV serostatus; however, additionally adjusting for serostatus reduced the effect of psychological resources (percent: gamma = -.41 [-93, .12]; number: (gamma = -.40 [-.94, .13]). Conclusions: Outside the context of the "Great Recession", psychological resources but not financial resources were associated with terminal maturity in T cells, a relationship related to CMV serostatus. Further studies in different and more diverse samples, and in different eras, are needed to understand what resources are most protective against immunological aging, when, and for whom.


  • Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18

    by Mikel B. Moore, Zoya B. Kurago, Colleen A. Fullenkamp, Charles T. Lutz

    Tumor cells stimulate natural killer (NK) cell effector functions, but the regulation of cytokine secretion and cytolysis is incompletely understood. We tested whether oral and pharyngeal squamous cell carcinoma cell lines differentially stimulated NK cell interferon-γ (IFN-γ) secretion and cytolysis using a clone of the NK-92-transformed human NK cell line, NK92.35. SCC-4 and SCC-25 cells, but not FaDu or Cal 27 cells, stimulated robust NK92.35 IFN-γ secretion. All four carcinoma cell lines were lysed by NK92.35 cells. These findings indicate that carcinoma cells differentially stimulate NK cell IFN-γ secretion and cytolysis. In Transwell experiments, a combination of SCC-4 or SCC-25 cell soluble factors and contact with FaDu cells synergistically stimulated NK92.35 cell IFN-γ secretion. Stimulatory SCC-4 cells constitutively secreted IL-18, a cytokine that potently augments IFN-γ secretion by T cells and NK cells. In contrast, poorly stimulatory FaDu cells produced little or no IL-18, but synergized with recombinant IL-18 to stimulate NK92.35 IFN-γ secretion. mAb to IL-18 or IL-18 receptor diminished SCC-4-stimulated IFN-γ secretion by NK92.35 cells and by nontransformed NK cells. Thus, IL-18 was necessary for optimal carcinoma stimulation of NK cell IFN-γ secretion. In vivo, oral and upper aerodigestive tract epithelia and carcinomas produced IL-18, but one squamous cell carcinoma had heterogeneous IL-18 expression. Thus IL-18 production can account for squamous cell carcinoma differential stimulation of NK cell effector functions in vitro and may be important for stimulation of NK cells in vivo.


  • Open Access

    DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells

    by Huei-Wei Chan, Zoya B. Kurago, C. Andrew Stewart, Michael J. Wilson, Maureen P. Martin, Brian E. Mace, Mary Carrington, John Trowsdale, Charles T. Lutz

    Killer immunoglobulin-like receptors (KIR) bind self–major histocompatibility complex class I molecules, allowing natural killer (NK) cells to recognize aberrant cells that have down-regulated class I. NK cells express variable numbers and combinations of highly homologous clonally restricted KIR genes, but uniformly express KIR2DL4. We show that NK clones express both 2DL4 alleles and either one or both alleles of the clonally restricted KIR 3DL1 and 3DL2 genes. Despite allele-independent expression, 3DL1 alleles differed in the core promoter by only one or two nucleotides. Allele-specific 3DL1 gene expression correlated with promoter and 5′ gene DNA hypomethylation in NK cells in vitro and in vivo. The DNA methylase inhibitor, 5-aza-2′-deoxycytidine, induced KIR DNA hypomethylation and heterogeneous expression of multiple KIR genes. Thus, NK cells use DNA methylation to maintain clonally restricted expression of highly homologous KIR genes and alleles.


  • Methylcholanthrene causes increased thymocyte apoptosis

    by Charles T Lutz, Garvan Browne, C.Rosemarie Petzold


  • Open Access

    Multicenter Evaluation of PCR Methods for the Detection of Factor V Leiden (R506Q) Genotypes

    by Charles T Lutz, Paul A Foster, Walter W Noll, Karl V Voelkerding, Richard D Press, Ronald C McGlennen, Nancy E Kirschbaum

    Activated protein C (APC) resistance is reported to be present in 20–60% of individuals with a history of venous thrombosis (1). Thus, the prevalence of APC resistance in Caucasian patients with a history of venous thromboembolism is much greater than the prevalence of protein C deficiency, protein S deficiency, or antithrombin deficiency (1). The APC resistance phenotype is associated with a guanine-to-adenine substitution at nucleotide 1691 of the factor V gene (1). This mutation produces a glutamine-for-arginine (R506Q) substitution at factor V residue 506 (factor V Leiden). The risk of thrombosis is increased five- to eightfold in individuals heterozygous for factor V Leiden and 30- to 140-fold in homozygous individuals (1). Coagulation-based assays for the detection of APC resistance have been described and are commercially available. The APC resistance ratios from some of these assay systems, however, have demonstrated overlap between unaffected individuals and individuals heterozygous for factor V Leiden (1). Newer coagulation-based assays have been reported, but it is not clear that they can be used in all clinical settings. Unlike coagulation-based assays for APC resistance, DNA-based assays are not affected by pregnancy, the therapeutic use of anticoagulants, the use of oral contraceptives, or the presence of inhibitors such as lupus anticoagulants. Therefore, a rapid and accurate nucleic-acid-based assay to detect the factor V Leiden mutation is highly desirable.


  • Open Access

    TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures

    by Yan Shi, Kelly D. Smith, Charles T. Lutz

    We investigated the peptide dependency of a group of CD8+ anti-HLA-B7 alloreactive CTL. The CTL killed target cells after acid denaturation of more than 98% of target cell surface peptide/MHC class I complexes. The CTL also killed TAP− HLA-B7-transfected T2 (T2B7) cells. The killing was enhanced by target cell incubation at 26°C. Despite these findings, which suggested peptide-independent allorecognition, CTL-mediated cytolysis was reduced or abolished by several point mutations affecting the HLA-B7 peptide-binding groove. Acid denaturation of HLA complexes on T2B7 cells prohibited CTL recognition. CTL recognition was restored by T2B7 cell incubation with β2-microglobulin and a single HPLC fraction containing peptides extracted from TAP+HLA-B7+ cells, but not by any of a panel of 17 synthetic HLA-B7-binding peptides. These findings indicated that CTL allorecognition was peptide specific. Sensitizing peptide was extracted from T2B7 cells only after incubation at 26°C. The amount of peptide detected in TAP+ cells was at least 10-fold and 100-fold greater than that detected in TAP− cells incubated at 26°C and at 37°C, respectively. TAP-independent peptide epitope presentation was sensitive to treatment with brefeldin A, but not sensitive to treatment with chloroquine, consistent with an endogenous peptide source. We propose that subphysiologic temperature incubation can enhance peptide/MHC class I presentation in the total absence of TAP function.


  • Open Access

    NK Cell Natural Cytotoxicity and IFN-γ Production Are Not Always Coordinately Regulated: Engagement of DX9 KIR+ NK Cells by HLA-B7 Variants and Target Cells

    by Zoya B. Kurago, Charles T. Lutz, Kelly D. Smith, Marco Colonna

    DX9 mAb-binding killer cell-inhibitory receptors (KIR) recognize HLA-B molecules that express the Bw4 public serologic epitope. We assessed DX9+ NK cell fine specificity recognition of HLA-B7 variants and HLA-B27 alleles by 51Cr release natural cytotoxicity assays and by flow cytometry and enzyme-linked immunospot (ELISPOT) IFN-γ synthesis and release assays. 721.221 target cell expression of Bw4+ HLA-B27 alleles specifically inhibited DX9+ NK cell natural cytotoxicity and IFN-γ synthesis and release. A triple substitution of HLA-B7 at residues 80, 82, and 83 known to induce expression of the Bw4 serologic epitope also specifically inhibited DX9+ NK cell natural cytotoxicity and IFN-γ responses. Single HLA-B7 amino acid substitution variants were recognized in the same decreasing rank order by DX9+ NK cells and Bw4-reactive mAbs: G83R > R82L > N80T = HLA-B7. Natural cytotoxicity inhibition was reversed by the presence of blocking DX9 mAb. Natural cytotoxicity and IFN-γ production were coordinately regulated by a panel of HLA-B7 variants expressed on 721.221 cells, suggesting that these two effector functions are inhibited by the same KIR-mediated signaling mechanisms. In contrast, some NK cell clones killed 721.221 and K562 target cells equally well but released much more IFN-γ in response to K562 target cells. Differential regulation of natural cytotoxicity and IFN-γ release shows that NK cell effector functions respond to distinct signals.


  • Conformational changes in MHC class I molecules

    by Kelly D. Smith, Zoya B. Kurago, Charles T. Lutz

    In this article we review the role of MHC conformation, including peptide-induced MHC conformation, in forming antibody (Ab), T-cell receptor (TCR), and natural killer (NK) cell receptor epitopes. Abs recognize conformational major histocompatibility (MHC) epitopes that often are influenced by the identity of MHC-bound peptide. Diverse TCRs recognize a common docking site on peptide/MHC complexes and directly contact peptide. Human NK cell inhibitory receptors (KIR) appear to recognize limited regions of the HLA α1 helix. DX9+ KIR specifically focus on HLA-B residues 82 and 83. However, NK cells recognize much broader regions of HLA class I molecules and are sensitive to bound peptides. Thus, several classes of lymphocyte receptors are peptidespecific. Peptide specificity could be the result of direct contact with the receptor, or to conformational shifts in MHC residues that interact with both receptor and bound peptide.


  • Correction of theHLA-Cw3 genomic sequence tentatively identifies it asHLA-Cw * 0304

    by Angela L. Zarling, Kelly D. Smith, Charles T. Lutz, David R. Lee